Century Therapeutics IPSC
NASDAQ IPSC
$1.60 -0.01 (-0.93%)
As of: Oct 22, 2026 · 3:44 PM EDT

Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Updated

Century Therapeutics (IPSC) posted EBT Margin of -8.84% for FY2025, up 1884.86 percentage points from -1893.70% in FY2024.

Analysis

Century Therapeutics (IPSC) EBT Margin (2022 - 2025) Analysis & Trends

Since FY2022, Century Therapeutics has reported EBT Margin for 4 years.

  • Annual EBT Margin shows a three-year change of +2507.82 percentage points (FY2022 to FY2025).
  • Business Quant data shows IPSC's EBT Margin at -1893.70% in FY2024 (+4137.26 pp), -6030.96% in FY2023 (-3514.30 pp) and -2516.66% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn 0.13%
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn 25.18%
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -4.11%
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn 29.63%
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn 18.19%
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn -131.41%
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn -4.34%
10 Century Therapeutics 328.22 Mn -176.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 70.13%
Dec 31, 2024 -821.88%
Sep 30, 2024 -3,948.67%
Jun 30, 2024 -4,044.75%
Mar 31, 2024 -3,281.99%
Dec 31, 2023 -15,025.00%
Sep 30, 2023 -21,708.11%
Jun 30, 2023 -32,667.68%
Mar 31, 2023 -1,747.44%
Dec 31, 2022 -6,074.86%
Sep 30, 2022 -1,381.47%
Jun 30, 2022 -2,218.48%
Mar 31, 2022 -3,544.14%
API Access

Century Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IPSC&period=max&api_key=YOUR_API_KEY